NCT02140814View on ClinicalTrials.gov

Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 29, 2016

Conditions
Polycystic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

Niacinamide

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

Alan Yu, MB, BChir

OTHER

NCT02140814 - Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease | Biotech Hunter | Biotech Hunter